ACTIVE

FELIX PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result201 €-47,4 %over 1 year

Gross margin-350 €+53,5 %over 1 year

Equity560,6 k €+0,0 %over 1 year

Identity

Source · BCE/KBO

FELIX PHARMA is a Public limited company incorporated in 2002. Its registered office is in Frameries.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0477.939.091
Incorporation: 09/07/2002
Legal form: Public limited company
Registered office: Rue Montavaux 155
7080 Frameries · WallonieSee on map
Contributed capital: 500 000,00 €
Latest accounts: 31/12/2025

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflow

Financials

Source · NBB, 19 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-350 €	+53.5%	-753 €	-4.4%	-721 €	+74.1%	-2,8 k €	-264%	-764 €
EBITDA	-750 €	+0.4%	-753 €	-4.4%	-721 €	+74.1%	-2,8 k €	-264%	-764 €
Operating result	-750 €	+0.4%	-753 €	-4.4%	-721 €	+74.1%	-2,8 k €	-264%	-764 €
Net result	201 €	-47.4%	382 €	+144%	-861 €	+71.3%	-3 k €	-236%	-894 €
Balance sheet
Equity	560,6 k €	+0.0%	560,4 k €	+0.1%	560 k €	-0.2%	560,9 k €	-0.5%	563,9 k €
Total assets	561 k €	+0.1%	560,4 k €	+0.1%	560 k €	-0.2%	560,9 k €	-0.5%	563,9 k €
Cash	170,4 k €	+0.5%	169,6 k €	-0.0%	169,6 k €	-0.5%	170,5 k €	-1.7%	173,5 k €
Debts	400 €		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMARepresented by PHILIPPE BOULANGER	Director18/03/2022 → 18/03/2028
GESTIPHARMA0425.530.684Represented by PIERRE-PASCAL HECQ	Managing director18/03/2022 → 18/03/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
DANIEL DECAMPS	Mandatelisted until the 2008 accountsChairman of the board of directors01/07/2008 → 2012 accounts
IMMOBILIERE SAINT GEORGES0435.700.442	Director01/07/2008 → 2009 accounts
JEAN MARIE DIDIER	Mandatelisted until the 2008 accounts

Other companies at this address

Rue Montavaux 155 7080 Frameries

Company	CBE no.
ASSCOT● Active	0447.778.625
ATRIUM MANAGEMENT● Active	0478.169.913
BEPHAR● Active	0450.260.538
EVRAS● Active	0417.723.174
FARMIMMO● Active	0429.198.175
IMMOBILIERE DES QUATRE SEIGNEURIES● Active	0443.155.782
Immobilière Général Léman● Active	0403.358.761
IMMOBILIERE PRIMA● Active	0466.956.812
IMMOBILIERE SAINT GEORGES● Active	0435.700.442
Les Pharmacies Réunies● Active	0403.082.213
OBIPHAR● Active	0878.100.418
PHARMACIE ANDROMEDE● Active	0882.318.631
PHARMACIE CLAERHOUT● Active	0423.162.203
Pharmacie de la Chasse Royale● Active	0867.368.654
PHARMACIE DE LA PLACE DE GHLIN● Active	0842.900.009
PHARMACIE FAIDHERBE● Active	0479.179.208
Pharmacie Grenez - Seeuws● Active	0419.745.130
PHARMACIE RONDEAU● Active	0447.088.737
PHARMACIE SCHNEIDER - DEPOUHON● Active	0439.400.397
PHARMANET● Active	0426.485.640

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	18 months	12 months	12 months
Filing date	30/06/2026	26/07/2025	23/07/2024	26/07/2023	15/11/2021	21/11/2020
General meeting	26/06/2026	30/06/2025	30/06/2024	30/06/2023	31/10/2021	31/10/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	26/06/2026	30/06/2026	French	PDF
Micro model	31/12/2024	30/06/2025	26/07/2025	French	PDF
Abridged model	31/12/2023	30/06/2024	23/07/2024	French	PDF
Micro model	31/12/2022	30/06/2023	26/07/2023	French	PDF
Micro model	30/06/2021	31/10/2021	15/11/2021	French	PDF
Micro model	30/06/2020	31/10/2020	21/11/2020	French	PDF
Micro model	30/06/2019	31/10/2019	04/11/2019	French	PDF
Micro model	30/06/2018	31/10/2018	07/11/2018	French	PDF
Micro model	30/06/2017	09/11/2017	04/12/2017	French	PDF
Abridged model	30/06/2016	31/10/2016	22/12/2016	French	PDF
Abridged model	30/06/2015	31/10/2015	03/03/2016	French	PDF
Abridged model	30/06/2014	31/10/2014	30/12/2014	French	PDF
Abridged model	30/06/2013	31/10/2013	29/11/2013	French	PDF
Abridged model	30/06/2012	31/10/2012	31/01/2013	French	PDF
Abridged model	30/06/2011	31/10/2011	12/01/2012	French	PDF
Abridged model	30/06/2010	31/10/2010	30/11/2010	French	PDF
Abridged model	30/06/2009	31/10/2009	21/12/2009	French	PDF
Abridged model	30/06/2008	31/10/2008	21/03/2009	French	PDF
Abridged model	30/06/2007	31/10/2007	15/11/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMARepresented by PHILIPPE BOULANGER	Director18/03/2022 → 18/03/2028
GESTIPHARMA0425.530.684Represented by PIERRE-PASCAL HECQ	Managing director18/03/2022 → 18/03/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
DANIEL DECAMPS	Mandatelisted until the 2008 accountsChairman of the board of directors01/07/2008 → 2012 accounts
IMMOBILIERE SAINT GEORGES0435.700.442	Director01/07/2008 → 2009 accounts
JEAN MARIE DIDIER	Mandatelisted until the 2008 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates22/06/2022
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates01/02/2016
DENOMINATION - SIEGE SOCIAL - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates23/02/2015
DEMISSIONS, NOMINATIONS
PDF
Capital / shares16/02/2012
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates05/07/2011
DEMISSIONS, NOMINATIONS - DIVERS
PDF
Registered office04/08/2003
OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

GESTIPHARMA

FINPHARMA

IMMOBILIERE SAINT GEORGES

JEAN MARIE DIDIER

DANIEL DECAMPS

JEAN-MARIE DIDIER

UNIVERSAL PHARMA

pierre-pascal hecq

PIERRE PASCAL HECQ

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

FELIX PHARMA

Rue Montavaux 155, 7080 Frameries

Managing director

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Montavaux 155, 7080 FrameriesCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00242423

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
FELIX PHARMACurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00242423

Events

2025
Annual accounts 2025201 €↓
2024
Annual accounts 2024382 €↑
2023
Annual accounts 2023-861 €↑
2022
Annual accounts 2022-3 k €↓
2021
Annual accounts 2021-894 €↓
2020
Annual accounts 2020-540 €↑
2019
Annual accounts 2019-581 €↓
2018
Annual accounts 2018-267 €↓
2017
Annual accounts 2017-229 €↑
2016
Annual accounts 2016-2,2 k €↓
2015
Annual accounts 2015-352 €↓
2014
Annual accounts 20141,9 k €↓
2013
Annual accounts 20133,5 k €↓
2012
Annual accounts 20127,5 k €↑
2011
Annual accounts 20111,7 k €↓
2010
Annual accounts 20109,6 k €↓
2009
Annual accounts 200921,4 k €↑
2008
Annual accounts 20088,5 k €↓
2007
Annual accounts 20079,4 k €
09/07/2002
IncorporationPublic limited company

FELIX PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events